26 completed, 26 recruiting, 22 active not recruiting, 11 terminated. 95 Phase 1, 22 Phase 2.
Follow Metastatic Malignant Solid Neoplasm: new trials by email Literature Review of Metastatic Malignant Solid Neoplasm trials Research Report on Metastatic Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer Biopsy Procedure, Biospecimen Collection, Echocardiography Test - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Recruiting | National Cancer Institute (NCI) | 36 | 2026-10-06 | 2026-10-16 |
| BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion Biospecimen Collection, Computed Tomography, Pemetrexed - Metastatic Biliary Tract Carcinoma, Metastatic Colon Carcinoma | Phase 1 / Phase 2 | Recruiting | Northwestern University | 72 | 2026-08-21 | 2026-08-25 |
| STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma Aldesleukin, Biopsy, Biospecimen Collection - Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma | Phase 1 | Withdrawn | City of Hope Medical Center | 2025-12-05 | 2025-12-24 | |
| MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Metastatic Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm | Phase 1 | Recruiting | Mayo Clinic | 42 | 2025-11-07 | 2026-09-24 |
| TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma TR-002 - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | University of California, Davis | 52 | 2025-11-07 | 2026-07-16 |
| Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors Biopsy, Biospecimen Collection, Computed Tomography - Metastatic Malignant Solid Neoplasm, Metastatic Melanoma | Phase 1 | Recruiting | Anusha Kalbasi | 18 | 2025-10-07 | 2026-03-17 |
| Imaging of Solid Tumors Using 18F-TRX 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy - Solid Tumor, Solid Carcinoma | Phase 1 | Recruiting | Rahul Aggarwal | 56 | 2025-07-03 | 2026-07-23 |
| Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 40 | 2025-07-01 | 2026-09-16 |
| Studying TAK-243 in Patients With Advanced Cancer Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Lymphoma, Advanced Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 95 | 2025-03-24 | 2026-10-13 |
| Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors Azenosertib, Biopsy Procedure, Biospecimen Collection - Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 1 | Recruiting | National Cancer Institute (NCI) | 48 | 2025-02-03 | 2026-10-27 |
| A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer Behavioral Intervention, Group Therapy, Psilocybin - Hematopoietic and Lymphatic System Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Completed | University of Washington | 15 | 2024-11-19 | 2025-10-14 |
| Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases Computed Tomography, Image Guided Radiation Therapy, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | City of Hope Medical Center | 24 | 2024-08-25 | 2026-10-28 |
| Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors Biopsy, Biospecimen Collection, Computed Tomography - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Withdrawn | Mayo Clinic | 2024-07-30 | 2025-01-07 | |
| Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 35 | 2024-06-12 | 2026-10-15 |
| Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 66 | 2024-06-07 | 2026-08-24 |
| Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors Axatilimab, Biopsy, Biospecimen Collection - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 / Phase 2 | Recruiting | OHSU Knight Cancer Institute | 38 | 2024-05-21 | 2026-07-08 |
| Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection - Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 30 | 2023-11-08 | 2026-10-28 |
| Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Malignant Solid Neoplasm, Advanced Microsatellite Stable Colorectal Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 42 | 2023-09-28 | 2026-07-31 |
| Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Recruiting | National Cancer Institute (NCI) | 45 | 2023-08-10 | 2026-11-12 |
| Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 43 | 2023-07-06 | 2026-08-03 |
Showing 20 of 95. Sign in to see all of them.
Neoplasm Metastasis (95) · Melanoma (18) · Lung Neoplasms (15) · Breast Neoplasms (13) · Triple Negative Breast Neoplasms (12) · Carcinoma, Non-Small-Cell Lung (10) · Colorectal Neoplasms (10) · Ovarian Neoplasms (10) · Pancreatic Neoplasms (10) · Carcinoma, Renal Cell (9) · Carcinoma, Transitional Cell (7) · Prostatic Neoplasms (7) · Carcinoma, Hepatocellular (6) · Hematologic Neoplasms (5) · Lymphoma (5)
Neoplastic Processes (95) · Pathologic Processes (95) · Pathological Conditions, Signs and Symptoms (95) · Neoplasms (92) · Neoplasms by Site (55) · Neoplasms by Histologic Type (35) · Skin Diseases (31) · Skin and Connective Tissue Diseases (31) · Digestive System Diseases (30) · Digestive System Neoplasms (30) · Urogenital Diseases (24) · Neoplasms, Glandular and Epithelial (23) · Carcinoma (22) · Genital Diseases (22) · Breast Diseases (21)
Specimen Handling (39) · Biopsy (37) · Magnetic Resonance Spectroscopy (31) · Nivolumab (13) · pembrolizumab (11) · CTLA-4 Antigen (10) · Ipilimumab (10) · Irinotecan (6) · Taxes (6) · X-Rays (6) · olaparib (6) · trametinib (6) · trastuzumab deruxtecan (6) · Carboplatin (5) · Cyclophosphamide (5)
National Cancer Institute (NCI) (48) · M.D. Anderson Cancer Center (20) · Mayo Clinic (5) · City of Hope Medical Center (4) · University of Washington (3) · Fred Hutchinson Cancer Center (2) · OHSU Knight Cancer Institute (2) · Pamela Munster (2) · Rahul Aggarwal (2) · University of California, Davis (2) · Anusha Kalbasi (1) · Northwestern University (1) · Ohio State University Comprehensive Cancer Center (1) · Ronald Levy (1) · Rutgers, The State University of New Jersey (1)
United States (90) · Canada (6) · Australia (1)
Timothy A Yap (7) · Aung Naing (2) · David S Hong (2) · Rahul Aggarwal, MD (2) · Sarina A Piha-Paul (2) · A P Chen (1) · Alex Adjei (1) · Alice P Chen (1) · Alison M Schram (1) · Allison Betof Warner, MD, PhD (1) · Ana Aparicio (1) · Andrea E Wahner Hendrickson (1) · Andrew Davis (1) · Anthony Back (1) · Anthony L. Back, MD (1)
PMID 39863139, PMID 27729313, PMID 28428884, PMID 31154457, PMID 33109741, PMID 33677480, PMID 33909232, PMID 34562230, PMID 34965890, PMID 35080914, PMID 35130943, PMID 35135810, PMID 35264434, PMID 35396812, PMID 35780243, PMID 36351402, PMID 36658425, PMID 36765881, PMID 37042037, PMID 37129197, PMID 37314501, PMID 37597578, PMID 37823909, PMID 37962072, PMID 38126764, PMID 38236249, PMID 38261444, PMID 38497709, PMID 38746220, PMID 39038917, PMID 39356983, PMID 39384194, PMID 39462179, PMID 39513363, PMID 39809926, PMID 39816915, PMID 39945382, PMID 39998620, PMID 40051480, PMID 40139261, PMID 40939237, PMID 41118283, PMID 41646361, PMID 41680482, PMID 42247927, PMID 42847673
UM1CA186709 (13), UM1CA186688 (7), UM1CA186689 (7), UM1CA186690 (7), U01CA062490 (6), UM1CA186644 (6), P30CA016672 (5), P30CA033572 (4), UM1CA186691 (4), UM1CA186716 (4), UM1CA186717 (4), UM1CA186686 (3), UM1CA186704 (3), ZIABC011078 (3), N01CM00100 (2)